Skip to main content
. 2019 Nov 29;34(3):e23107. doi: 10.1002/jcla.23107

Figure 6.

Figure 6

P4HA1 genetic alterations in HNSCC and its correlation with prognosis of HNSCC patients in OS and DFS. A, P4HA1 is altered in 1.6% (8/504) of sequenced HNSCC patients. B, P4HA1 genetic alterations were associated with significantly worse overall survival; C, P4HA1 genetic alterations were associated with significantly worse disease‐free survival